» Articles » PMID: 25065409

Empirical Evidence for Discrete Neurocognitive Subgroups in Bipolar Disorder: Clinical Implications

Overview
Journal Psychol Med
Specialty Psychology
Date 2014 Jul 29
PMID 25065409
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent data suggest trait-like neurocognitive impairments in bipolar disorder (BPD), with deficits about 1 s.d. below average, less severe than deficits noted in schizophrenia. The frequency of significant impairment in BPD is approximately 60%, with 40% of patients characterized as cognitively spared. This contrasts with a more homogeneous presentation in schizophrenia. It is not understood why some BPD patients develop deficits while others do not.

Method: A total of 136 patients with BPD completed the MATRICS Consensus Cognitive Battery and data were entered into hierarchical cluster analyses to: (1) determine the optimal number of clusters (subgroups) that fit the sample; and (2) assign subjects to a specific cluster based on individual profiles. We then compared subgroups on several clinical factors and real-world community functioning.

Results: Three distinct neurocognitive subgroups were found: (1) an intact group with performance comparable with healthy controls on all domains but with superior social cognition; (2) a selective impairment group with moderate deficits on processing speed, attention, verbal learning and social cognition and normal functioning in other domains; and (3) a global impairment group with severe deficits across all cognitive domains comparable with deficits in schizophrenia.

Conclusions: These results suggest the presence of multiple cognitive subgroups in BPD with unique profiles and begin to address the relationships between these subgroups, several clinical factors and functional outcome. Next steps will include using these data to help guide future efforts to target these disabling symptoms with treatment.

Citing Articles

Clinical Characteristics of Cognitive Subgroups of Obsessive Compulsive Disorder.

Misir E, Tukel R, Akdede B, Bora E Brain Behav. 2025; 15(3):e70375.

PMID: 40079623 PMC: 11904946. DOI: 10.1002/brb3.70375.


Clinical practice guidelines on cognitive impairment in bipolar disorders - Assessment and management.

Kesavan M, Rathi L, Sinha N, Reddy P, Bhaskar M Indian J Psychiatry. 2025; 67(1):84-97.

PMID: 40046484 PMC: 11878457. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_696_24.


The role of blood-brain barrier dysfunction in cognitive impairments in bipolar disorder-a narrative review.

Millett C, Monir F, Sanelli P Front Hum Neurosci. 2025; 19:1504575.

PMID: 40046427 PMC: 11880004. DOI: 10.3389/fnhum.2025.1504575.


Impact of Anticholinergic Burden on Cognitive Functions in Individuals with Bipolar Disorder, Schizoaffective Disorder, and Schizophrenia.

Oktar Erdogan N, Yucens B, Tumkaya S Clin Psychopharmacol Neurosci. 2025; 23(1):76-85.

PMID: 39820114 PMC: 11747743. DOI: 10.9758/cpn.24.1184.


Multivariate patterns among multimodal neuroimaging and clinical, cognitive, and daily functioning characteristics in bipolar disorder.

Damgaard V, Fortea L, Schandorff J, Macoveanu J, Little B, Gallagher P Neuropsychopharmacology. 2025; .

PMID: 39789327 DOI: 10.1038/s41386-024-02047-2.


References
1.
Martinez-Aran A, Torrent C, Tabares-Seisdedos R, Salamero M, Daban C, Balanza-Martinez V . Neurocognitive impairment in bipolar patients with and without history of psychosis. J Clin Psychiatry. 2008; 69(2):233-9. DOI: 10.4088/jcp.v69n0209. View

2.
Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea J, Salamero M . Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007; 9(1-2):103-13. DOI: 10.1111/j.1399-5618.2007.00327.x. View

3.
Altman E, Hedeker D, Janicak P, Peterson J, Davis J . The Clinician-Administered Rating Scale for Mania (CARS-M): development, reliability, and validity. Biol Psychiatry. 1994; 36(2):124-34. DOI: 10.1016/0006-3223(94)91193-2. View

4.
Rosa A, Bonnin C, Vazquez G, Reinares M, Sole B, Tabares-Seisdedos R . Functional impairment in bipolar II disorder: is it as disabling as bipolar I?. J Affect Disord. 2010; 127(1-3):71-6. DOI: 10.1016/j.jad.2010.05.014. View

5.
Burdick K, Goldberg T, Cornblatt B, Keefe R, Gopin C, DeRosse P . The MATRICS consensus cognitive battery in patients with bipolar I disorder. Neuropsychopharmacology. 2011; 36(8):1587-92. PMC: 3138672. DOI: 10.1038/npp.2011.36. View